An analytical review on the quantitative techniques for estimation of cilostazol in pharmaceutical preparations and biological samples

An analytical review on the quantitative techniques for estimation of cilostazol in pharmaceutical preparations and biological samples

Cilostazol (CLZ) is a quinolinone derivative possessing anti platelet and vasodilating properties and it is used in the treatment of intermittent claudication. It operates by inhibiting the cyclic guanosine monophosphate (cGMP) dependent phosphodiesterase III which leads to availability of cyclic ad...

Full description

Bibliographic Details
Main Authors:	Afreen Afnaan, Nalini C.N.
Format:	Article
Language:	English
Published:	De Gruyter 2021-04-01
Series:	Reviews in Analytical Chemistry
Subjects:	cilostazol phosphodiesterase iii inhibitors (pde iii) intermittent claudication pharmaceutical formulations biological fluids analytical methods
Online Access:	https://doi.org/10.1515/revac-2021-0128

Similar Items

Safety and efficacy of cilostazol in the management of intermittent claudication
by: Yung-Wei Chi, et al.
Published: (2008-12-01)

Premature Ventricular Contractions (PVCs) Induced by Administration of Cilostazol after Myocardial Infarction
by: Lihua Zhong, et al.
Published: (2013-02-01)

Contribuição na prevenção da isquemia cerebral pelo cilostazol, um inibidor da fosfodiesterase III: revisão de literatura Contribution to prevention of cerebral ischemia by cilostazol, a phosphodiesterase III inhibitor: a review
by: Marcelo Pereira da Rosa, et al.
Published: (2008-03-01)

Avaliação in vivo do cilostazolnanoencapsulado em artéria carótida de ratos Wistar: estudo interdisciplinar
by: Nascimento, Núbia da Silva
Published: (2018)

Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome
by: Masahiro Tsuji, et al.
Published: (2020-04-01)

Evaluation of Contraceptive Properties of Cilostazol (A Phosphodiesterase 3A Inhibitor) in Mice
by: Taiyeb-Ridha, Ahmed 1979-
Published: (2013)

Evaluation of antidepressant and anxiolytic activity of phosphodiesterase 3 inhibitor - Cilostazol
by: Dipesh S Patel, et al.
Published: (2012-01-01)

Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: Implication of cilostazol for diabetes mellitus-induced dementia
by: Kyoung Ja Kwon, et al.
Published: (2015-01-01)

Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model
by: Noriaki Nagai, et al.
Published: (2015-12-01)

Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death
by: Joseph Longo, et al.
Published: (2020-10-01)

VASOACTIVE DRUGS IN CRITICAL CARE
by: Dusper Silva, et al.
Published: (2014-07-01)

Vasoactive drugs in critical care
by: Dusper Silva, et al.
Published: (2014-07-01)

Spectrophotometric Determination of Sulphadiazine in Pharmaceutical Preparations Via Arsenazo III - Cerium (III) Reaction
by: Nabeel Othman, et al.
Published: (2007-06-01)

Cilostazol for the prevention of pneumonia: a systematic review
by: Hirotaka Nakashima, et al.
Published: (2018-04-01)

Peripheral artery disease: potential role of ACE-inhibitor therapy
by: Giuseppe Coppola, et al.
Published: (2008-12-01)

The effect of sequential intermittent pneumatic compression of foot and calf on popliteal artery mean systolic blood flow in patients with intermittent claudication
by: Daphne Anthonysamy, et al.
Published: (2012-10-01)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
by: Kenjiro Ono, et al.
Published: (2019-05-01)

Phosphodiesterase-4 Inhibition in Psoriasis
by: Milakovic M, et al.
Published: (2021-03-01)

Synthesis of a new organic probe 4-(4 acetamidophenylazo) pyrogallol for spectrophotometric determination of Bi(III) and Al(III) in pharmaceutical samples
by: Ammar Jumana W., et al.
Published: (2021-04-01)

Cilostazol, um inibidor da fosfodiesterase 3, reverte as alterações vasculares induzidas pelo envelhecimento em artérias mesentéricas de resistência de rato
by: MOREIRA, Hicla Stefany Nunes
Published: (2016)

Positive chronotropic effects of theophylline and cilostazol in patients with symptomatic sick sinus syndrome who have declined permanent pacing
by: In Tae Jin, Namsik Yoon, Hyung Ki Jeong, Ki Hong Lee, Hyung Wook Park, Jeong Gwan Cho
Published: (2020-09-01)

Effects of phosphodiesterase inhibitors on secretions of human monokines
by: Yuji Suda, et al.
Published: (1998-01-01)

Limitações para caminhar em idosos com claudicação intermitente: a religiosidade como mecanismo de superação da dor
by: Ana Raquel Mendes dos Santos, et al.

Management of secondary risk factors and the effects of combination aspirin clopidogrel on platelet function in claudicants
by: Cassar, Kevin
Published: (2003)

Lumbar Spinal Stenosis and Intermittent Neurogenic Claudication
by: Cumhur Ertekin, et al.
Published: (2010-06-01)

Lumbar Spinal Stenosis and Intermittent Neurogenic Claudication
by: Cumhur Ertekin, et al.
Published: (2010-06-01)

The blue pill (sildenafil) and its descendants: an overview
by: Krzanowski Tomasz, et al.
Published: (2017-09-01)

The evaluation of surgical reconstruction for intermittent claudication by the Walking Impairment Questionnaire Avaliação da reconstrução cirúrgica para claudicação intermitente pelo Walking Impairment Questionnaire
by: Masaya Nakashima, et al.
Published: (2010-12-01)

Sildenafil in pediatric pulmonary arterial hypertension
by: A K Dhariwal, et al.
Published: (2015-01-01)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
by: Juraj Mokry, et al.
Published: (2021-04-01)

DESCRIPTION OF EFFECTIVENESS OF CILOSTAZOL AND ASPIRIN AS ADJUVANT OF DIABETIC FOOT WAGNER GRADE II AND III
by: Pandji Winata Nurikhwan, et al.
Published: (2014-09-01)

DESCRIPTION OF EFFECTIVENESS OF CILOSTAZOL AND ASPIRIN AS ADJUVANT OF DIABETIC FOOT WAGNER GRADE II AND III
by: Pandji Winata Nurikhwan, et al.
Published: (2014-09-01)

Thiocyanatochrome complexes in analytical chemistry: Determination of osmium(III)
by: Bratulescu George, et al.
Published: (2005-01-01)

Thiocyanatochrome complexes in analytical chemistry. Determination of osmium(III)
by: GEORGE BRATULESCU, et al.
Published: (2005-09-01)

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
by: Susann Schröder, et al.
Published: (2016-05-01)

Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016
by: Susann Schröder, et al.
Published: (2021-04-01)

CILOSTAZOL FOR TREATMENT OF PATIENTS WITH DIABETIC LEG ULCERS
by: Ihor Kobza, et al.
Published: (2017-10-01)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
by: Marianna Szczypka
Published: (2020-08-01)

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
by: Shinichiro Uchiyama, et al.
Published: (2015-01-01)

Physical Characteristics of Cilostazol–Hydroxybenzoic Acid Cocrystals Prepared Using a Spray Drying Method
by: Maho Urano, et al.
Published: (2020-04-01)